Bora secures FDA approval for CDMO services

The Taiwanese oral solid drugmaker specialises in modified release (MR) and solvent production

picture of

Breaking News

Cell Therapies gains first T-Cell GMP manufacturing licence in Australia

The licence allows for the collection, manufacturing, testing, storage and release for the supply of any commercial T- ...

Acino establishes partnership to increases presence in the UAE

Acino will work with the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences to provide services in ...

Chinese CDMO purchases former Novartis API facility

Zhejiang Jiuzhou Pharmaceutical has committed to guarantee continuous supply of products manufactured by the former ...

Process optimisation with flow chemistry

WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more ...

Civica Rx and Exela Pharma join forces to help shortage of sodium bicarbonate

Exela has agreed to manufacture and supply sodium bicarbonate injection that has been in critically short supply in US ...

Mallinckrodt sells BioVectra CDMO for $250 million

The Canadian CDMO will continue to supply an API for UK-based Mallinckrodt's specialty brands business under a long- ...

Case Study: Phase I to commercial in 18 months

Gabor Heltovics, Druggability Technologies CEO, talks about using Quotient Sciences to progress and scale-up an ...

Particle Dynamics expands to upgrade CDMO services

New innovation centre includes development laboratories and pilot-scale processing rooms for spray drying, m ...

ReAgent launches biological reagent manufacturing service

The chemical manufacturer and packaging company has achieved ISO 13485 accreditation for medical devices

Small molecule CDMOs reacting to changing market demands

The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...

Stainless steel products in contemporary bioprocessing

ASEPCO's Mark Embury on the shift from stainless steel to single-use systems in the pharmaceutical manufacturing sector

WuXi Biologics CEO: Vaccine CDMO is the next area of growth

Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion

SK Group merges affiliates to launch US-based CMO

The South Korea-based group will launched the new entity in 2020 to be called SK Pharmteco, based in Sacramento, ...

South Korean Celltrion picks Lonza to diversify and expand manufacturing

Existing capacity sits at 190,000 L of drug substance each year